Cardiomedex is a highly skilled preclinical CRO specialized in the cardiovascular field. Cardiomedex conducts reliable studies that optimize the preclinical development of drug candidates for the treatment of cardiovascular diseases and cardiometabolic complications.
Our large selection of gold standard animal models covers cardiovascular disorders such as:
Heart failure with preserved or reduced ejection fraction
Myocardial infarction
Cardiac hypertrophy
Hypertension
Endothelial dysfunction
Anthracycline cardiotoxicity
Along with in vivo models, we offer a state-of-the-art platform for functional exploration & pharmacological characterization using ex-vivo and in vitro assays.
In addition to CRO services, we provide our clients with personalized consulting services in line with the pharma industry’s emerging trends.
Company Details
- Employees
- 9
- Founded
- -
- Address
- 280 Rue De L’hers, Zac De La Masquère, Escalquens,31750,france
- Industry
- Research Services
- NAICS
-
Scientific Research and Development ServicesResearch and Development in the Physical, Engineering, and Life SciencesResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Website
- cardiomedex.com
- Keywords
- Preclinical contract research, CRO, In vivo efficacy models, Cardiovascular safety, In vitro / ex vivo assays, Cardiac function, BRET, Cardiovascular disorders, Vascular reactivity, Cardiotoxicity, Proof of concept, Aortic rings.
- HQ
- Escalquens
Cardiomedex Questions
Cardiomedex's website is cardiomedex.com
Cardiomedex's LinkedIn profile is https://fr.linkedin.com/company/cardiomedex
Cardiomedex has
9 employees.
View email and phone details for 9
employees at Cardiomedex.
Cardiomedex's industry is
Research Services
Cardiomedex's top competitors are
Mimabs Sas,
Urosphere,
Edelris,
Imavita,
Antabio,
Physiogenex,
Xentech,
Janvier Labs,
Jc Discovery,
Yecuris Corporation.
Cardiomedex's categories are Research Services
Cardiomedex's founding year is 2010
